​

Keros Therapeutics (KROS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Keros Therapeutics Revenue Highlights

Latest Revenue (Y)

$244.06M

Latest Revenue (Q)

$367.00K

Main Segment (Y)

License

Keros Therapeutics Revenue by Period

Keros Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$244.06M6774.96%
2024-12-31$3.55M2250.99%
2023-12-31$151.00K100.00%
2022-12-31--100.00%
2021-12-31$20.10M100.00%
2020-12-31--100.00%
2019-12-31$10.00M-
2018-12-31$10.00M-

Keros Therapeutics generated $244.06M in revenue during NA 2025, up 6774.96% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Keros Therapeutics Revenue by Quarter

DateRevenueChange
2026-03-31$367.00K-4.68%
2025-12-31$385.00K-97.30%
2025-09-30$14.26M-21.50%
2025-06-30$18.17M-91.40%
2025-03-31$211.25M6844.31%
2024-12-31$3.04M684.02%
2024-09-30$388.00K948.65%
2024-06-30$37.00K-55.42%
2024-03-31$83.00K-41.96%
2023-12-31$143.00K1687.50%
2023-09-30$8.00K100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$20.00M100.00%
2021-09-30--100.00%
2021-06-30$100.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$2.50M-
2019-09-30$2.50M-
2019-06-30$2.50M-
2019-03-31$2.50M-

Keros Therapeutics generated $367.00K in revenue during Q1 2026, up -4.68% compared to the previous quarter, and up 12.06% compared to the same period a year ago.

Keros Therapeutics Revenue Breakdown

Keros Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 22Dec 21
Service, Other$38.71M---
License$205.35M$144.00M$144.00M$144.00M
Service-$3.00M--

Keros Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (84.14%), and Service, Other (15.86%).

Quarterly Revenue by Product

Product/ServiceMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21
Service, Other$367.00K$385.00K$4.26M$18.17M$15.89M$83.00K---------
License--$10.00M$195.35M$144.00M$144.00M$144.00M$144.00M$18.00M$20.00M$100.00K----
Service-----$2.60M$400.00K--------

Keros Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Service, Other (100.00%).

Keros Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RIGLRigel Pharmaceuticals$294.28M$58.82M
KROSKeros Therapeutics$244.06M$367.00K
RGNXREGENXBIO$170.44M$6.39M
NAGENiagen Bioscience$99.60M$29.13M
CTMXCytomX Therapeutics$76.20M$10.26M
VSTMVerastem$30.91M$18.67M
ABSIAbsci$2.80M-
CRVSCorvus Pharmaceuticals--
VTYXVentyx Biosciences--
MLTXMoonLake Immunotherapeutics--
OLMAOlema Pharmaceuticals--

KROS Revenue FAQ

What is Keros Therapeutics’s yearly revenue?

Keros Therapeutics's yearly revenue for 2025 was $244.06M, representing an increase of 6774.96% compared to 2024. The company's yearly revenue for 2024 was $3.55M, representing an increase of 2250.99% compared to 2023. KROS's yearly revenue for 2023 was $151K, representing an increase of 100.00% compared to 2022.

What is Keros Therapeutics’s quarterly revenue?

Keros Therapeutics's quarterly revenue for Q1 2026 was $367K, a -4.68% decrease from the previous quarter (Q4 2025), and a -99.83% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $385K, a -97.30% decrease from the previous quarter (Q3 2025), and a -87.34% decrease year-over-year (Q4 2024). KROS's quarterly revenue for Q3 2025 was $14.26M, a -21.50% decrease from the previous quarter (Q2 2025), and a 3575.77% increase year-over-year (Q3 2024).

What is Keros Therapeutics’s revenue growth rate?

Keros Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 161529.80%, and for the last 5 years (2021-2025) was 1114.23%.

What are Keros Therapeutics’s revenue streams?

Keros Therapeutics's revenue streams in c 25 are Service, Other, and License. Service, Other generated $38.71M in revenue, accounting 15.86% of the company's total revenue License generated $205.36M in revenue, accounting 84.14% of the company's total revenue, up 42.61% year-over-year.

What is Keros Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Keros Therapeutics was License. This segment made a revenue of $205.36M, representing 84.14% of the company's total revenue.